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Abstract
Persistent infection of the mouse central nervous system (CNS) with mouse hepatitis virus (MHV) induces a
demyelinating disease pathologically similar to multiple sclerosis and is therefore used as a model system.
There is little information regarding the host factors that correlate with and contribute to MHV-induced
demyelination. Here, we detail the genes and pathways associated with MHV-induced demyelinating disease
in the spinal cord. High-throughput sequencing of the host transcriptome revealed that demyelination is
accompanied by numerous transcriptional changes indicative of immune infiltration as well as changes in the
cytokine milieu and lipid metabolism. We found evidence that a Th1-biased cytokine/chemokine response
and eicosanoid-derived inflammation accompany persistent MHV infection and that antigen presentation is
ongoing. Interestingly, increased expression of genes involved in lipid transport, processing, and catabolism,
including some with known roles in neurodegenerative diseases, coincided with demyelination. Lastly,
expression of several genes involved in osteoclast or bone-resident macrophage function, most notably
TREM2 and DAP12, was upregulated in persistently infected mouse spinal cord. This study highlights the
complexity of the host antiviral response, which accompany MHV-induced demyelination, and further
supports previous findings that MHV-induced demyelination is immune-mediated. Interestingly, these data
suggest a parallel between bone reabsorption by osteoclasts and myelin debris clearance by microglia in the
bone and the CNS, respectively. To our knowledge, this is the first report of using an RNA-seq approach to
study the host CNS response to persistent viral infection.
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Abstract
Persistent infection of the mouse central nervous system (CNS) with mouse hepatitis virus (MHV) induces a
demyelinating disease pathologically similar to multiple sclerosis and is therefore used as a model system. There is
little information regarding the host factors that correlate with and contribute to MHV-induced demyelination. Here, we
detail the genes and pathways associated with MHV-induced demyelinating disease in the spinal cord. High-
throughput sequencing of the host transcriptome revealed that demyelination is accompanied by numerous
transcriptional changes indicative of immune infiltration as well as changes in the cytokine milieu and lipid
metabolism. We found evidence that a Th1-biased cytokine/chemokine response and eicosanoid-derived
inflammation accompany persistent MHV infection and that antigen presentation is ongoing. Interestingly, increased
expression of genes involved in lipid transport, processing, and catabolism, including some with known roles in
neurodegenerative diseases, coincided with demyelination. Lastly, expression of several genes involved in osteoclast
or bone-resident macrophage function, most notably TREM2 and DAP12, was upregulated in persistently infected
mouse spinal cord. This study highlights the complexity of the host antiviral response, which accompany MHV-
induced demyelination, and further supports previous findings that MHV-induced demyelination is immune-mediated.
Interestingly, these data suggest a parallel between bone reabsorption by osteoclasts and myelin debris clearance by
microglia in the bone and the CNS, respectively. To our knowledge, this is the first report of using an RNA-seq
approach to study the host CNS response to persistent viral infection.
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Introduction
Mouse hepatitis virus (MHV) is a positive-sense RNA virus of
the coronaviridae family. MHV strain A59 is both hepatotropic
and neurotropic, and intracranial inoculation of mice causes
acute hepatitis and encephalitis and subsequent demyelination.
MHV-,A59 replicates in the brain, spinal cord and liver, peaking
at about five days post infection after which time infectious
virus is cleared primarily by the CD8T cell response, also
requiring CD4T cells. Although virus is cleared by 10-14 dpi
from all organs, viral RNA persists in the central nervous
system (CNS) and is accompanied by inflammatory
demyelination, which peaks in the spinal cord at approximately
one month post-infection [1-6]. Demyelinating strains of MHV
(A59 and JHM) have been widely used as models for the study
of the human demyelinating disease multiple sclerosis [1,7-10].
MHV-induced CNS disease involves recurring demyelination
and remyelination in spinal cords of infected mice [5,6,11],
suggesting that this model has pathological similarities to the
remitting-relapsing forms of multiple sclerosis.
The mechanisms underlying MHV-induced demyelination
remain unclear. Although MHV induces primary demyelination,
axonal damage has also been observed in MHV-infected CNS
[12]. Early pathological studies suggested that demyelination
results from direct infection of and damage to
oligodendrocytes, the myelin producing cells of the CNS
[13,14]. More recent reports have implicated
immunopathological mechanisms rather than oligodendrocyte
damage in MHV-induced demyelination, although the specific
pathways involved still remain to be determined. While RAG-/-
mice, lacking mature B- and T-cells, do not undergo
demyelination, neither CD4 nor CD8T-cells are absolutely
required [2,8]. Virus-specific T cells persist in the CNS [15,16],
and both macrophages and microglia are associated with
demyelinating lesions [14]. Mice lacking B-cells exhibit more
severe demyelination than immunocompetent mice, throughout
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the course of infection [2], but this is likely due at least in part to
persistence of infectious virus. Additionally, several cytokines
have been studied in the context of MHV-induced
demyelination; only IP-10 is reported to affect the clinical
course of disease [17-21]. While many demyelinating disorders
are also presumed to involve dysregulation of lipid metabolism
and transport [22-25], there are to date no reports of alterations
of lipid metabolism during MHV infection.
To comprehensively characterize the gene expression
changes and pathways affected by MHV-induced
demyelination in the murine CNS, we employed high-
throughput RNA sequencing (RNA-seq) using spinal cords
from MHV-A59-infected mice at 33 days post-infection, around
the time of maximum MHV-induced demyelination as quantified
luxol fast blue staining of spinal cord sections [1,2,5,26]. At this
time post infection, demyelination is robust and viral genome
expression is detectable [1,2,5,16,26]. To our knowledge, this
is the first report of using RNA-seq to detail the host response
to virus-induced demyelinating disease. We found that the host
response to MHV persistence was characterized by a Th1-
biased cytokine response, eicosanoid-associated inflammation,
ongoing antigen presentation, lymphocyte proliferation and
activation, and lipid processing changes. In addition, the
expression levels of several genes involved in osteoclast
function, or the function of bone-resident macrophages, were
augmented in the demyelinating CNS, most likely being
expressed by brain resident microglia. Two of these genes,
TREM2 and DAP12, were among the most highly induced
during MHV-induced demyelinating disease. Interestingly,
natural polymorphisms in these genes lead to a demyelinating
disorder in humans concurrent with osteopetrosis, or bone
cysts [27-30]. The increased expression of genes that directly
affect bone resorption and osteoclasts during demyelination
leads to the intriguing possibility that osteoclasts and microglia
may have parallel roles in maintaining the specialized
extracellular matrix of their respective compartments.
Materials and Methods
Mice, viruses, and cells
C57/Bl6 (B6) mice were obtained from the National Cancer
Institute (Frederick, MD). Four-week-old mice were inoculated
intracranially with 2000 plaque-forming units (pfu) of MHV-A59
[7] or an equal volume of uninfected cell lysate (mock infected)
in 25 µL of PBS containing 0.75% BSA, and tissues were
harvested at the indicated dpi. Tissues were flash frozen for
later RNA isolation, fixed in phosphate buffered formalin for
tissue embedding, or frozen in saline with 0.167% gelatin for
titering of infectious virus. Standard plaque assays were
performed on transformed mouse fibroblast L2 cells as
described previously [31].
Ethics Statement
All mouse procedures were performed on protocols
approved by the University of Pennsylvania’s Institutional
Animal Care and Use Committee (IACUC) (Reference
Assurance # A3079-01). Intracranial inoculations were carried
out under anesthesia with isoflurane and all efforts were made
to minimize suffering. The University Of Pennsylvania School
Of Medicine is fully accredited by the Association for the
Assessment and Accreditation of Laboratory Animal Care
International (AAALAC).
Isolation of primary murine cells
Bone marrow-derived macrophages (BMM) were generated
from the hind limbs of B6 mice as described previously [32,33].
Briefly, bone marrow was differentiated into macrophages by
growth in L929 fibroblast secreted M-CSF. Macrophages were
seeded after 6-7 days in vitro.
Neurons were isolated from the hippocampi of E15.5-16.5
mouse embryos and plated on poly-L-lysine coated wells
without astrocyte feeder layers as described previously [34,35].
Hippocampal neuron cultures were typically >95% pure as
assessed by immunostaining with an antibody recognizing
MAP2 (1:2; AP14, kindly provided by Virginia Lee, University of
Pennsylvania).
Primary glial cultures were established as described
previously [36], with the following modifications. For isolation of
astrocytes, confluent mixed glial cultures were shaken on day
4-7 in vitro to dissociate the loose top layer of microglia, which
were discarded. The remaining adherent cells, mostly
astrocytes, were trypsinized and re-plated at a 1:2 dilution. This
procedure was repeated on day 13-15. Prior to seeding, the
astrocytes were passed through a series of three suspension
cell culture plates for 20 minutes each at room temperature to
allow adhesion of contaminating microglia and fibroblasts. For
isolation of microglia, mixed glial cultures were shaken on
d13-15 and the cells in the supernatant re-plated. The medium
was replaced after 30 minutes to remove contaminating
astrocytes, which adhere more slowly. Astrocyte and microglial
cultures were each >95-99% pure as assessed by
immunofluorescence staining with monoclonal antibodies
directed against GFAP for astrocytes (Dako Z0334) and CD11b
for microglia (Abcam ab6332) as described previously [35].
Mouse oligodendrocyte cultures were derived from a mixed
population of cells isolated from the forebrains of 1- to 3-day-
old neonatal C57/BL6 mice and cultured in serum-free growth
medium containing PDGF, FGF2, and NT-3, as previously
described [37]. When confluent, the oligodendrocyte-lineage
cells were purified using a modified wash down procedure to
remove astrocytes and other contaminating cells [37].
Persistence experiment
Brain lysates were cleared of cell debris by centrifugation at
3,000 rpm for fifteen minutes. A portion of the supernatant was
removed and centrifuged at 13,000 rpm for three minutes.
Twenty microliters of this supernatant was then injected into
each of 3-5 naïve four-week old B6 mice. These mice were
observed for clinical symptoms of disease, and their brains,
spinal cords, and livers were harvested at the indicated dpi.
Extracts from the second round of mice were titered by
standard plaque assay and assayed for characteristic
cytopathic effects of MHV on L2 mouse fibroblast cells. The L2
fibroblast lysates were then assayed for viral RNA using
polymerase chain reaction (PCR) with primers specific to the
viral subgenomic mRNA7.
Host Transcriptome in MHV-Induced Demyelination
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Real time quantitative reverse transcriptase-PCR (qRT-
PCR)
Total RNA was isolated from homogenized tissue or cultured
cells using either RNeasy mini kit columns (Qiagen) or TRIzol
(Gibco) according to the manufacturer’s instructions and
depleted of DNA using Turbo DNase (Ambion). qRT-PCR was
performed as described previously [38] on each biological
replicate. Briefly, 350 ng of total RNA (from cells or tissue) was
transcribed into cDNA using the Superscript III reverse
transcript kit (Invitrogen). Then, 2 µl of cDNA was combined
with 12.5 µl of iQ5 SYBR green mix (Bio-Rad, Hercules, CA),
6.5 µl of DEPC-treated water, and 4 µl of mixed primers (5 µM
each), DNA was amplified using an iQ5 iCycler (Bio-Rad), and
cycle threshold (CT) values were recorded. Basal mRNA levels
were expressed as ΔCT, that is, relative to the level of β-actin
mRNA (ΔCT= CT gene of interest -CT ß-actin ). The expression levels in
infected spinal cords relative to those in mock-infected spinal
cords (fold changes) were expressed as 2-∆∆CT.
Illumina library preparation and sequencing
Tissues were solubilized in TRIzol, and total RNA was
isolated and DNase-treated as described above. Poly-A-
containing mRNA was selected from 20 µg of RNA pooled from
5 mice using the Dynabeads mRNA direct kit (Invitrogen). The
mRNA was fragmented, a 5’ phosphate was added using T4
polynucleotide kinase (Invitrogen), and the library was size-
selected (60-200 nucleotides) on a 15% TBE-urea gel. Illumina
v1.5 RNA adapters were ligated to ends of the fragmented
products using T4 RNA ligase 2 (New England Biolabs). A
cDNA library was generated using Superscript II (Invitrogen)
and PCR-amplified using Phusion HiFi DNA polymerase (New
England Biolabs). The library was purified on a 6% TBE gel
(Invitrogen). The quality of the library was verified prior to
Illumina sequencing by cloning into Zero Blunt TOPO
(Invitrogen) and analyzing 6-10 clones by standard sequencing
to determine a) the presence of adapters, b) appropriate size
selection, c) the abundance of ribosomal RNA, and d) the
diversity of the library products. The verified size-selected poly-
A stranded cDNA library was submitted to the Penn Genome
Frontiers Institute (PGFI, University of Pennsylvania,
Philadelphia, PA) for sequencing. The Illumina Solexa GAII
platform was used to obtain 50-bp single-end sequencing
reads, which were analyzed using the v1.5 pipeline.
Computational Analysis
The reads were aligned to the mm9 genome using Bow tie
[39]. Differential expression was analyzed using DESeq [40] in
the R statistical environment (www.r-project.org/). Transcripts
with a fold induction ≥ 2 and Benjamini-Hochbery adjusted p-
value ≤ 0.05 were considered significant and included in
downstream analysis. Gene ontology (GO) analysis [41] was
performed using the Database for Annotation, Visualization,
and Integrated Discovery (DAVID) online resource. Pathway
analysis was also performed using DAVID [42], and enriched
categories and pathways were further examined by qRT-PCR
analysis. Genes involved in myelination, osteoclast function,
oligodendrocyte differentiation, lipid/cholesterol transport and
metabolism, and cytokine activity were queried from the GO
database (http://www.geneontology.org/), and the resulting
Mus musculus gene information from these lists were used to
assess the expression of these genes in the MHV datasets.
The data were deposited in the Gene Expression Omnibus
(GEO) at the National Center for Biotechnology under
accession number GSE44333.
Results
MHV genome and mRNA, but not infectious virus,
persist in the central nervous system (CNS) of infected
B6 mice
MHV persistence is a well-documented phenomenon, but the
extent to which viral transcription and translation occur at late
time points (one month or later) post infection are not clear
[1,13,43]. Here, we have employed a highly sensitive assay for
detection of infectious virus in conjunction with targeted
amplification of genomic and messenger RNA to investigate
the presence of viral components in the spinal cord during
chronic disease. Four-week-old C57Bl/6 (B6) mice were
inoculated intracranially with MHV-A59 and infectious viral
titers in several organs quantified. During acute infection, that
is, the first week, mice exhibited characteristic hunching,
ataxia, depression, ruffled fur, and weight loss.
MHV titers peaked 5 days post infection (dpi), and by 10-14
dpi infectious virus was no longer detectable in any of the
organs as assayed by standard plaque assay (Figure 1A, data
not shown). By 10-14 dpi, the mice began regaining weight and
resumed their normal grooming habits and activity levels.
Although infectious virus and clinical signs were no longer
detectable, viral genomic RNA and subgenomic mRNAs
persisted in the brain (Figure 1B) and, to higher levels, in the
spinal cord (Figure 1C). These viral mRNAs were detectable by
reverse transcriptase-quantitative polymerase chain reaction
(qRT-PCR) until at least 60 dpi, suggesting a low level of
ongoing transcription. During the persistent phase of infection,
some mice exhibited minor weight loss, ruffled fur and slight
depression, while a few mice also experienced hindlimb
paresis of several days’ duration. By 60 dpi, all mice had
completely recovered to similar weights as uninfected animals
and exhibited normal hindlimb movement. Luxol fast blue
staining of spinal cord sections taken from mice at 33 dpi,
approximately at the peak of demyelinating disease [1,2,5,26]
showed characteristic demyelinating lesions (data not shown).
To investigate whether very low levels of infectious virus
(below the level of detection by plaque assay) are produced
during the demyelinating phase of MHV infection, we used an
in vivo bioassay to probe for infectious MHV in persistently
infected tissues. Brain lysates from the above infected (donor)
mice (taken on 5, 7, 14, 33, and 44 dpi) were injected into
naïve four-week-old recipient mice, which were observed for
clinical signs of infection (Table 1) and sacrificed 5 and 7 dpi, at
the peak times of replication and encephalitis, respectively. The
recipient mice that were inoculated with brain lysates of donor
mice sacrificed 5 or 14 dpi, but not from donor mice sacrificed
33 or 44 dpi, exhibited clinical symptoms of MHV disease.
Recipient mice that were inoculated with 5 dpi donor mouse
extract experienced weight loss, ataxia, hunching, and ruffled
Host Transcriptome in MHV-Induced Demyelination
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fur, as well as visible necrosis in the liver on dpi 7. Mice
inoculated with 14 dpi donor mouse extract experienced
minimal weight loss and clinical signs but had detectable titers
of infectious virus in both the brain and liver 5 and 7 dpi (Table
1 and data not shown).
Finally, the brains and livers harvested from recipient mice
were assessed for infectious virus by treatment of L2
fibroblasts, which are sensitive to MHV infection, with these
extracts. Cells were then assayed for viral nucleocapsid
mRNA7 and genome by qRT-PCR as well as observed for
cytopathic effects (Table 1). Again, only the extracts from
recipient mice that had been inoculated with extract from 5 or
14 dpi donor mice produced any cytopathic effect or viral RNA
in L2 cells. These data confirm that infectious virus is not
present in the CNS, as it was not detectable even by a very
sensitive bioassay, during MHV-induced demyelinating
disease, while both genomic and subgenomic viral RNAs
remained detectable.
MHV-induced demyelinating disease alters the
transcriptome of host spinal cord tissue
To characterize the host response during the demyelinating
phase of disease, total RNA was extracted from spinal cords of
both mock- and MHV-infected B6 mice sacrificed 33 dpi. Poly-
adenylated RNA was selected and the resulting library
subjected to 50-bp Illumina Solexa GAII sequencing (Table
S1). We used the DESeq package (http://www-huber.embl.de/
users/anders/DESeq/) to analyze the changes in the host
transcriptome during the demyelinating phase of MHV-A59
infection and found 909 transcripts for which expression was
significantly altered (894 upregulated, 14 downregulated).
Although 24,321 of the 27,731 annotated transcripts in the
mouse genome (NCBI Build 37) were expressed at similar
levels in mock-infected and MHV-infected animals (Figure S1),
only 2,502 transcripts were not expressed at all in either mock-
infected or MHV-infected spinal cord.
Figure 1.  Replication of MHV in mice.  Four-week old B6 mice were infected intracranially with 2000 pfu of MHV-A59 and
sacrificed at the indicated days post infection. A) Brains were harvested and placed in gelatin saline, homogenized and infectious
virus titered on mouse L2 fibroblasts. Titers shown are averages from five mice per group. B) Brains and C) spinal cords were
harvested and RNA isolated on Qiagen RNeasy columns. qRT-PCR was performed to quantify relative abundance of MHV-A59
genomic and subgenomic RNA mRNA7. Data are plotted as means with SEM of 5-8 mice.
doi: 10.1371/journal.pone.0075346.g001
Host Transcriptome in MHV-Induced Demyelination
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Next, we used the gene ontology (GO) database and the
database for annotation, visualization and integrated discovery
(DAVID) to characterize the 894 transcripts for which
expression was upregulated in infected spinal cord (Table S2).
Subsets of these genes were found to be involved in antigen
presentation and processing, inflammation, defense, and
immune responses, chemotaxis and cytokine signaling,
complement, and lipid processing, transport, storage, and
metabolism (Figure 2 and Table S3). A small number of these
genes were expressed at undetectable levels in spinal cord
from mock-infected mice but at significant levels in spinal cord
from MHV-infected mice (65 genes, starred in Table S2).
These genes encode proteins that perform immunological
functions, including surface markers expressed exclusively on
myeloid or lymphoid cells (24 genes), cytokines (5 genes),
lysosomal components (3 genes), granzyme B, apolipoproteins
C-II and C-IV, and a complement component (Cfb). Neither
complement components nor active B/T-cells nor their products
would be expected to be present in the spinal cord in naïve
mice; therefore, these data illuminate the utility of this assay for
detecting transcriptional changes reflective of infiltrating
immune cells. The 50 most highly differentially expressed
transcripts, which are representative of the functional
categories in Figure 2, are listed in Table 2.
The RNA-seq results were validated by performing qRT-PCR
on several transcripts for which expression was significantly
increased in infected tissue and all transcripts assayed
exhibited similar fold changes in expression between the two
techniques (Figure S2). Additionally, total RNA was extracted
Table 1. Virus persistence in mice.
Day of isolation
from donor
mouse (brain)*
Day of isolation
from recipient
mouse (brain)** Clinical symptoms***
Cytopathic effect
of brain extract on
L2 cells (recipient
mouse)****
5 5
Weight loss, ataxia,
hunching, ruffled fur
Yes
 7
Weight loss, ataxia,
hunching, ruffled fur,
necrotic liver
Yes
14 5 None, brain titer Yes
 7 Weight loss, brain titers Yes
33 5 No No
 7 No No
44 5 No No
 7 No No
* Four-week old mice were infected intracranially with 2000pfu of MHV-A59 and
brains were harvested from donor mice on indicated day post infection.
** The cleared brain lysate from donor mice was injected into naïve four-week old
recipient mice and brains were harvested from these mice on days 5 and 7 post
infection.
*** Recipient mice were observed for clinical symptoms until they were sacrificed.
The titers, if there were assayed, are indicated here.
**** Lysate from recipient mice was placed on L2 cells and cells were watched for
cytopathic effects which include syncytia, cell death, and rounding.
doi: 10.1371/journal.pone.0075346.t001
from the spinal cords of a second set of infected mice and the
relative expression of several genes in four categories of genes
that were upregulated during demyelination (described below)
were validated by qRT-PCR. Thus the RNA-seq data were
validated technically by qRT-PCR and biologically by
comparison with RNA from an independent set of infected mice
(Figure 3).
Th1 cytokine and chemokine gene expression is
upregulated during MHV-chronic CNS disease
The expression levels of genes encoding several cytokines/
chemokines, as well as their receptors, were upregulated in the
spinal cords of infected mice harvested 33 dpi (Table S4).
Twenty-six of these genes encode cytokine or chemokine
activities, 29 are involved in cytokine production or regulation,
and many others encode proteins involved in cytokine binding
or signaling pathways (Figure 2 and Table S3). The genes
encoding two Th1 chemokines, CXCL9 and CCL5, were
among the top fifty most highly upregulated genes (Table 2).
Increased expression levels of four Th1 chemokines were
validated by qRT-PCR in biological replicates from mice
persistently infected with A59 (Figure 3A).
Genes involved in antigen presentation pathways have
increased expression during MHV-chronic CNS disease
GO analysis also indicated that expression of 34 genes
involved in antigen processing and presentation was
upregulated in spinal cord during the persistent phase of MHV
infection (Figure 2 and Table S3). Twenty of these genes
encode major histocompatibility complex alleles, including eight
MHC II and 12 MHC I alleles, 14 of which are non-classical
(Table 2, Tables S3 and S5). In addition to MHC alleles, CD74,
the gamma chain of the MHC II protein, and CD8α, the MHC I
receptor [44], are also highly overrepresented in the spinal
cords of persistently infected animals (Table 2, Figure 3B and
Table S5). The increased expression levels of MHC alleles H2-
Eb1 and H2-D1, CD74 (a transporter associated with antigen
processing binding protein (TAPBP) [45,46]), and cathepsin Z
(a lysosomal cysteine protease potentially involved in the
degradation of viral antigens [47]), were confirmed by qRT-
PCR using the spinal cord of MHV-infected animals in a
second experiment (Figure 3B).
Genes associated with lipid metabolism and transport
have increased expression during MHV chronic CNS
disease
We found that MHV infection induced major changes in the
transcription of genes involved in many facets of lipid
metabolism. In fact, expression levels of 22 genes whose
protein products are components of chylomicrons, low-density
lipoprotein, or very-low-density lipoprotein particles were
increased in the demyelinating spinal cord. Interestingly,
expression levels of 12 genes involved in lipid transport,
including apolipoproteins E, C1, C2, and C4, were also
upregulated (Table 2, Tables S3 and S6). Eleven other genes
for which expression was enhanced in MHV-infected spinal
cord encode proteins with lipase or phospholipase activity
Host Transcriptome in MHV-Induced Demyelination
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Figure 2.  Gene Ontology Analysis.  The transcripts for which expression was significantly upregualted (894 transcripts) were
analyzed using the functional annotation tool in DAVID and using only the molecular function, cellular component, and biological
process terms in the gene ontology database. The most significant and non-redundant categories are represented here. The
percentages of the 894 upregulated genes that are involved in each category are represented.
doi: 10.1371/journal.pone.0075346.g002
Host Transcriptome in MHV-Induced Demyelination
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Table 2. Top 50 Differentially Expressed Genes**.
NCBI Accession*** Gene symbol Fold Change (log2) P-value
Antigen presentation    
NM_010378 H2-Aa 8.091196867 5.24E-38
NM_010545 Cd74 7.559236329 1.23E-37
NM_207105 H2-Ab1 7.164195919 9.97E-33
NM_010382 H2-Eb1 6.078669952 7.39E-26
NM_013532 Lilrb4* 7.153079999 5.53E-20
NM_009857 Cd8a* 7.247316069 5.82E-18
NM_010724 Psmb8 4.256179268 6.92E-15
Complement    
NM_021334 Itgax 7.520522753 3.12E-27
NM_009779 C3ar1 5.279252321 2.59E-19
NM_007572 C1qa 4.42367613 3.59E-17
NM_009777 C1qb 4.147839729 1.56E-15
NM_007574 C1qc 4.195323372 1.72E-15
Associated with lymphocytes (T, B,NK)   
NM_152839 Igj 7.28755371 1.55E-31
NM_007654 Cd72 6.36344867 5.95E-21
NM_008534 Ly9 6.437381518 5.53E-20
NM_144539 Slamf7 6.979726259 1.10E-19
NM_013706 Cd52 5.404143569 1.87E-19
NM_009850 Cd3g 6.89889651 4.92E-18
NM_009857 Cd8a* 7.247316069 5.82E-18
NM_013489 Cd84 4.961200073 2.36E-17
NM_008147 Gp49a* 8.808431827 6.92E-15
NM_009845 Cd22 5.403189838 6.92E-15
Cytokines and receptors    
NM_008599 Cxcl9 8.457703361 7.22E-26
NM_013653 Ccl5 8.138965713 3.68E-23
Lipid transport and metabolism   
NM_009853 Cd68* 5.132714539 1.32E-18
NM_009695 Apoc2 5.960434921 1.48E-17
NM_007385 Apoc4 6.306136984 3.17E-16
NM_031195 Msr1* 5.445227457 1.24E-15
Associated with myeloid cells (macrophages, DCs):  
NM_053110 Gpnmb* 8.23606446 6.56E-42
NM_009977 Cst7* 7.995478697 5.88E-36
NM_027836 Ms4a7 7.415825374 2.26E-26
NM_010705 Lgals3* 5.361533229 7.20E-22
NM_010821 Mpeg1 4.794347075 2.26E-19
NM_011662 Tyrobp* 4.812736142 4.20E-19
NM_009853 Cd68* 5.132714539 1.32E-18
NM_031254 Trem2* 4.734450912 1.35E-18
NM_145634 Cd300lf* 5.577795412 3.07E-17
NM_009690 Cd5l 7.137739453 3.80E-17
NM_031195 Msr1* 5.445227457 1.24E-15
NM_011426 Siglec1 6.552776952 2.08E-15
NM_008147 Gp49a* 8.808431827 6.92E-15
Pathogen destruction    
NM_017372 Lyz2 7.261341918 4.11E-35
NM_013590 Lyz1 7.022574167 1.51E-32
NM_020008 Clec7a 6.380384706 4.54E-26
NM_007807 Cybb 6.264961456 1.38E-25
NM_010705 Lgals3* 5.361533229 7.20E-22
NM_021792 Iigp1 5.022735652 2.36E-17
(Figure 2, Table 2, Tables S3 and S6). For example, CD36
[48], CD68 [49], MSR1, and four other genes (Table S6)
encode macrophage scavenger receptors responsible for
phagocytosing macromolecules, cellular debris, and/or oxidized
lipid-protein particles.
Eicosanoids, lipid-derived mediators of inflammation that are
classified as leukotrienes or prostanoids, are synthesized in
response to a variety of stimuli. Several eicosanoid genes in
either the prostaglandin or leukotriene pathways showed
increased expression in infected CNS tissue (Table S6). The
expression levels of ten other genes either upstream of or
involved in eicosanoid metabolism were upregulated in the
MHV infected CNS (Figure 2, Tables S3 and S6). Additionally,
a subset of lipid processing genes that have increased
expression in infected tissue include several genes known to
be involved in human neurodegenerative diseases (Figure 3C).
Mutations in hexaminidase A, hexaminidase B, Niemann-Pick
type C2, and ATP-binding cassette transporter A1 (ABCA1)
cause Tay-Sachs [50], Sandhoff disease [51], Niemann-Pick
type C2 (NPC2) [52], and Tangier disease [53], respectively.
Differential expression of oligodendrocyte-associated
genes is not associated with MHV- chronic CNS
disease
Myelin- and oligodendrocyte-associated genes were not
among those expressed at higher levels in MHV-A59 infected
versus mock-infected spinal cord (Figure S3 and Table S7).
More specifically, genes encoding proteo-lipid protein 1 (PLP1),
Table 2 (continued).
NCBI Accession*** Gene symbol Fold Change (log2) P-value
Osteoclast function    
NM_053110 Gpnmb* 8.23606446 6.56E-42
NM_175406 Atp6v0d2 8.109994462 4.53E-25
NM_016873 Wisp2 6.415273428 2.94E-22
NM_013532 Lilrb4* 7.153079999 5.53E-20
NM_011662 Tyrobp* 4.812736142 4.20E-19
NM_031254 Trem2* 4.734450912 1.35E-18
NM_007388 Acp5(TRAP) 6.54687635 4.82E-18
NM_145634 Cd300lf* 5.577795412 3.07E-17
Other    
NM_009977 Cst7 7.995478697 5.88E-36
NM_023044 Slc15a3 5.351815911 2.18E-19
NM_019984 Tgm1 6.482855955 3.05E-18
Unknown function    
NM_028595 Ms4a6c 5.706251433 2.36E-17
NM_001033767 Gm4951 5.673905156 3.80E-17
NM_001081957 Gm11428 6.094571593 6.44E-16
* These genes are represented in more than one category
** Alternatively spliced isoforms were collapsed into one gene category. The top 50
differentially expressed genes as determined by DESeq are represented. Fold
change values are log2 transformed.
*** The common gene symbol and the associated NCBI accession number are
both listed.
doi: 10.1371/journal.pone.0075346.t002
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MBP, myelin oligodendrocyte protein (MOG), myelin-
associated protein (MAG), and other structural protein
components of the myelin sheath were expressed at similar
levels in mock and infected tissue. Similarly, Olig1, 2, and 3
and Sox 8, 9, and 10, which are transcription factors
associated with oligodendrocyte differentiation [54-60] (Figure
S3 and Table S7), were not more highly expressed in spinal
cords of infected mice.
Increased expression of genes with roles in osteoclast
development and function, including TREM2 and
DAP12 is associated with MHV chronic CNS disease
Microglia are CNS-resident macrophages and have
specialized functions for maintaining homeostasis in their
specific environment. Unsurprisingly, 36 genes involved in the
differentiation, maturation, and function of myeloid-lineage cells
showed increased expression in the 33-dpi MHV-infected
spinal cord (Table 2, Figure 2, Tables S2 and S3). These
genes are involved in scavenging (CD68, MSR1), signaling
(Ms4a7, Tyrobp, TREM2, Gp49a, and AIM [61-66]), pathogen
destruction (Lgals3 [67]), and monocyte differentiation (Tyrobp,
TREM2, Mpeg1, and gpnmb [68-73]). Two of the genes for
which expression was most highly induced during MHV
persistence were TREM2 (Triggering receptor expressed on
myeloid cells 2) and DAP12 (DNAX-activating protein of
12kDa), both of which are involved in myeloid differentiation
and function (Table 2). In humans, congenital natural
polymorphisms that cause loss of function mutations in either
TREM2 or DAP12 result in Nasu-Hakola disease, which is
characterized by late-onset demyelination in the CNS and
osteopetrosis [27-30]. Interestingly, several other myeloid-
specific genes in addition to TREM2 and DAP12 that exhibited
increased expression levels in demyelinating spinal cord are
also important for osteoclast differentiation and function (Figure
3D and Table S8). Indeed increased expression of tartrate-
resistant acid phosphatase (Acp5), bone sialoprotein (spp1),
Figure 3.  Biological validation of genes of interest.  The expression of genes in several categories that were upregulated during
MHV induced chronic disease A) Th1 chemokines; B) antigen presentation; C) lipid metabolism and neurodegenerative disease and
D) osteoclast differentiation, maturation, and function was quantified by qRT-PCR analysis of spinal cord derived RNA from an
independent set of infected mice. Oligonucleotide primers and qRT-PCR were used to detect expression of 4-5 genes in each
category. Fold changes of mRNA transcripts in infected mice were determined relative to mock infected and compared to mRNA
fold change levels determined in the RNA-seq experiment. All genes analyzed had significantly increased expression in infected
mice as compared to mock infected, similar to observations in the RNA-seq analysis. qRT-PCR data plotted are means with SEM of
5 mice.
doi: 10.1371/journal.pone.0075346.g003
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osteopontin and oncostatin M receptor was associated with
chronic MHV induced CNS disease (Table S4).
Because natural mutations in TREM2 and DAP12 lead to
demyelinating disease in humans and these genes are
associated with demyelination in this model, we chose to study
the expression of TREM2 and DAP12 mRNA expression levels
in the brain, spinal cord, and liver in 33-dpi infected and mock-
infected animals (Figure 4A). In the uninfected mouse, TREM2
is expressed at high levels in the brain and spinal cord, but at
minimal levels in the liver, while DAP12 shows higher and more
ubiquitous expression in all organs assayed. We also assessed
the basal expression levels of TREM2 and DAP12 in CNS cell
types cultured in vitro (Figure 4B). DAP12 was expressed in all
cell types, with much higher expression in myeloid cells,
whereas TREM2 was expressed solely in myeloid cells, with
astrocytes, oligodendrocytes, and neurons showing minimal to
no detectable expression of this gene (Figure 4B). In the 33-dpi
MHV-infected animals, TREM2 expression was upregulated
strongly in the spinal cord and to lesser extents in the brain and
liver (Figure 4C). Infection increased DAP12 expression
significantly only in the infected spinal cord and not in the brain
or liver (Figure 4C).
Discussion and Conclusions
Other and we have reported that MHV genome RNA persists
in the CNS for the lifetime of the mouse despite the inability to
detect infectious virus during MHV chronic disease [2,74,75]. A
previous study comparing persisting and non-persisting strains
of MHV indicates that virus-specific CD8T-cells persist only
when viral RNA is present and that viral persistence also
correlates with demyelination [76]. Therefore, although
infectious virus does not appear to persist in the CNS of MHV-
infected mice, the viral products that do persist may be the viral
mediators of the demyelinating pathology. Here, we report that
even by using an extremely sensitive in vivo bioassay,
Figure 4.  TREM2/DAP12 mRNA expression.  A) Expression of TREM2/DAP12 mRNA was determined by qRT-PCR in RNA from
spinal cord, brain, and liver of mock infected mice (n=3-5 mice). B) Expression of basal levels of TREM2/DAP12 mRNA was
determined by qRT-PCR in RNA from primary cell cultures (oligodendrocytes, n= 2; macrophages, n= 4; neurons, n= 6; astrocytes
and microglia, n=5). C) Virus induced levels of TREM2/DAP12 mRNA expression were determined by qRT-PCR in RNA from spinal
cord, brain, and liver of infected mice, 33 dpi. Data plotted are means with SEM.
doi: 10.1371/journal.pone.0075346.g004
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persistently infected CNS tissue is unable to transfer infectious
virus to naïve hosts. We furthermore demonstrated that viral
mRNA as well as genomic RNA persists suggesting viral
transcription is occurring and perhaps mRNA is translated into
protein that is responsible for maintenance of T cells during
persistence as well as the demyelinating pathology. The nature
of persistent MHV mRNA is not yet known and requires
additional studies, now underway, to characterize the viral
sequences, including their mutation rate(s), the presence of six
subgenomic mRNAs, leader-junction diversity in subgenomic
species, and relative abundance of negative-sense RNA
species.
Many different biological activities are hypothesized to lead
to demyelination and neurodegeneration in the CNS. Activated
lymphocytes and inflammation-mediated responses may
directly or indirectly induce death in oligodendrocytes, thus
interfering with maintenance of the myelin sheath. The role of
oligodendrocytes, the cells that specialize in myelination, in
supporting MHV persistence and demyelinating disease has
been disputed. Previous studies have shown that MHV persists
selectively in oligodendrocytes [11,13,14,77-82]. An early study
reported that MHV antigens were present in the
oligodendrocytes of demyelinating lesions four weeks post
infection [4]. Some studies show that oligodendrocytes are
directly damaged during MHV infection but it has also been
shown that oligodendrocytes in the MHV infected brain are not
apoptotic, and MHV-induced demyelination correlates with
inflammation rather than direct damage to oligodendrocytes
[14,83,84]. In contrast to MHV infection, immunization against
myelin basic protein (MBP) results in direct damage to
oligodendrocytes and EAE [85-87] and leads to reduced
expression of many oligodendrocyte or myelin-specific genes in
the CNS [88,89]. Here we report no changes in expression of
oligodendrocyte specific, or myelination-relevant genes during
MHV-induced demyelinating disease supporting the hypothesis
that oligodendrocytes are not specifically damaged during MHV
persistence. It is important to note here that remyelination also
occurs during MHV induced chronic disease and that while not
maximal until ten weeks post infection, remyelination-
associated genes may be upregulated at 33 dpi. However, our
data suggests remyelinating processes at this time post
infection do not appear to involve increased expression of
oligodendrocyte specific genes.
Activated lymphocytes and inflammatory responses can also
be damaging to neurons and other cells of the CNS and may
contribute to the immune-mediated pathology observed during
demyelination. We report here that Th1 chemokines (CCL5,
CCL3, CXCL10, CXCR3, CXCR4) have augmented expression
during MHV-induced demyelinating disease. CCL5 and CCL3
attract T-cells and other leukocytes to sites of inflammation
[90-93], while CXCR4 is a T-cell receptor that promotes
chemotaxis to sites of inflammation [94]. CXCL10 (IP-10) and
its receptor CXCR3 recruit many immune cells to inflammatory
sites and have been previously shown to influence MHV-
induced demyelination [17]. Additionally, CXCL10 has been
extensively studied in two models of multiple sclerosis, MHV,
and experimentally induced autoimmune encephalitis (EAE).
Additionally, antibody-mediated blockade of this cytokine has
ameliorated disease in both models [17,95]. The combination
of increased expression of several canonical Th1 cytokines/
chemokines and absent expression of the canonical Th2
cytokines/chemokines [96-101] supports the hypothesis that
the host is continuing to mount a cell-mediated immune
response to the virus, as previously suggested [102].
Antigen presenting cells activate and recruit lymphocytes to
sites of infection and this pathway remains upregulated during
MHV-induced demyelinating disease. Several non-classical
MHC alleles have augmented expression as well and the roles
of these alleles in persistent infection, CNS infection, and
demyelination are completely unknown. The MHC II locus is a
confirmed multiple sclerosis susceptibility locus in humans
[103], and it is possible that certain MHC alleles may also be
important for the establishment of MHV-induced demyelination.
Although infectious virus does not persist in the CNS, the
CD8T-cell response to viral antigen is known to continue in the
CNS through this time period [16,76,104,105], and CD8T-cell
exhaustion has been proposed to contribute to MHV
persistence [106]. Indeed, the sustained activation of
lymphocytes, which is associated with sustained antigen
presentation, is established not just for MHV-induced
demyelination [1,43,107-112], but also for EAE [87,113,114]
and multiple sclerosis [115-117], lending evidence to the theory
that demyelination is an immunopathological process possibly
triggered by diverse biological activities.
The importance of lipid metabolism in general in myelination
and demyelination is undisputed. As lipid is a major component
of the myelin sheath, changes in lipid metabolism may
influence the composition, degradation, or regeneration of
myelin in the CNS. Thus, the set of genes related to lipid
transport, differentially expressed during MHV-induced chronic
disease may be important not only for the formation of the
myelin sheath but also for remyelination during MHV infection
or in diseases such as MS. Indeed by 33 dpi in the MHV
model, while demyelination is the predominant pathology; the
remyelination process has likely begun [6]. Thus, increased
expression of many lipid processing genes during MHV-
induced chronic CNS disease likely represents both processes.
Several genes associated with neurodegenerative disease in
humans have highly increased expression during MHV-induced
demyelinating disease (HexA, HexB, NPC2, ABCA1, apoE,
CD36) [50]. Patients with genetic disorders affecting these
genes have greatly reduced amounts of myelination.
Furthermore, a variant of apolipoprotein E, apoEε4, is a genetic
risk factor for Alzheimer’s disease [118,119], and focal
demyelination has been observed near amyloid-beta plaques in
both humans and mice [120]. CD36 has been shown to be
involved in peripheral nerve remyelination after injury [121].
The expression levels of both CD36 and ABCA1 are also
upregulated in demyelinating spinal cord tissue from mice with
EAE [88]. In addition, CD36 [122] and apoE [123,124] have
recently been associated with the active phase of relapsing-
remitting MS.
Additionally, genes involved in the eicosanoid production
pathway are also upregulated in the demyelinating CNS. Our
data indicate that upregulation of expression of eicosanoid-
derived inflammatory mediators may be involved in
Host Transcriptome in MHV-Induced Demyelination
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demyelinating disease, although whether these eicosanoids
contribute to or limit the pathology remains undetermined.
Regardless, the modulation of eicosanoid-mediated
inflammation in demyelinating CNS tissue is under active
investigation [125].
Macrophages and microglia promote viral clearance and
clear cellular debris; therefore, changes in these cells, as well
as in oligodendrocytes, may promote myelin loss and/or alter
the host ability to remyelinate during acute infection.
Macrophages/microglia have been clearly associated with the
pathology of MHV induced demyelinating disease [14,126,127].
A group of myeloid-specific genes that have proven importance
for osteoclast function or bone maintenance was also
upregulated during MHV-induced demyelination (Table S4).
Two of the most highly regulated genes were DAP12 and
TREM2. DAP12 is a signaling adapter that associates with
multiple receptors in different cell types [128] and signals
through an ITAM motif [62]. TREM2 signals exclusively through
DAP12 and is expressed on myeloid cells in response to
unknown ligands [129,130]. Polymorphisms in either of these
genes found in individuals with, Nasu-Hakola disease cause
demyelination and osteopetrosis, presumably resulting from
defects in microglia and osteoclasts respectively [27-30].
DAP-12 deficient mice also exhibit a similar phenotype [131].
DAP12 expression is also associated with NKG2D T-cells in
the CNS, which have been demonstrated to contribute to MHV-
induced demyelination [132]. Other myeloid-specific genes that
were upregulated during MHV induced chronic disease are
also important for osteoclast differentiation and function, for
example Acp5, Spp1, osteopontin, oncostatinM. Mice deficient
in Acp5 exhibit osteopetrosis [133,134]. Bone sialoprotein
(Spp1) anchors osteoclasts to bone and is a major component
of the bone extracellular matrix [135], while osteopontin has
been examined as a modulator of demyelination due to its
increased expression in EAE tissue and cerebrospinal fluid
from multiple sclerosis patients [136,137]. Lastly, the oncostatin
M receptor is also highly expressed in MHV-infected and EAE-
and MS-affected tissues [88,138]. Interestingly, infusion of
oncostatin M into mice with chemically induced demyelination
also regulated the expression of several genes involved in the
differentiation of oligodendrocyte precursor cells into mature
myelinating cells [139].
Previous studies have confirmed the expression of TREM2 in
human microglia, with conflicting results concerning the
expression of TREM2 in neurons or oligodendrocytes [140].
Here we show that TREM2 expression is most highly
expressed in microglia and macrophages, while DAP12
expression was detected in neurons and astrocytes as well.
Interestingly, these genes are more highly induced at 33 dpi in
the spinal cord as compared to the brain. This is consistent
with studies suggesting that MHV persistence ( [141] and
Figure 1) as well as demyelination [142] is to a greater is extent
in the spinal cord than in the brain.
Taken together, our findings suggest that osteoclasts and
microglia may have several parallel functions. It is known that
osteoclasts reabsorb bone (which is created by osteoblasts)
using superoxides to destroy the bone matrix and specialized
forms of phagocytosis [143,144]. Regulation of osteoclast and
osteoblast function is critical for bone homeostasis, and a lack
of osteoclast activity caused by mutations in any of several
genes leads to osteopetrosis or bone cysts [144,145]. Similarly,
microglia, along with inflammatory macrophages, may reabsorb
damaged myelin and thus allow oligodendrocytes to
remyelinate. Osteoclasts have been reported to present
antigen, activate T-cells, and secrete cytokines in vitro [146], as
microglia have been shown to do in the CNS [147]. Osteoclasts
also respond to multiple cytokines that regulate their
differentiation and bone-resorptive activity [148], while
microglia and inflammatory macrophages are activated by
cytokines to scavenge myelin debris [126]. The parallels
between osteoclastic and microglial functions in bone
remodeling of skeletal tissue and myelin remodeling of the
CNS may currently be underappreciated. In support of this
model, our findings here indicate a unique role for a subset of
bone remodeling proteins in the remyelinating CNS during
persistent MHV infection, perhaps by specific expression in
activated microglia.
Finally, this study provides the first transcriptome-wide
description of gene expression in the spinal cord of mice with
MHV-induced demyelination. The data described here provide
a basis on which to investigate these pathways in more detail.
This includes understanding the pathways contributing to
demyelination and/or perhaps remyelination, defining the cell
types in which the expression of each of these classes of
genes is induced as well as the times post-infection at which
each group of genes is upregulated. Further studies will also
focus on assessing the influences of translational and post-
translational mechanisms that likely constitute another level of
the host response to chronic MHV infection.
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Figure S1.  Expression of RefSeq transcripts. Expression of
each transcript was determined using DESeq in the R
statistical background. The current RefSeq database (26,823
transcripts) for Mus musculus was divided into four categories:
significantly increased expression (log2 fold change over mock
≥ and p < 0.05), significantly decreased expression (log2 fold
change over mock ≤ 1 and p < 0.05), similar expression (-1<
log2 fold change over mock < 1), and no expression (neither
mock nor MHV-A59 infected had any reads to the transcript).
(TIFF)
Figure S2.  RNA-seq technical validation. The expre≤ssion
of nine transcripts was analyzed by RNA-seq and qRT-PCR
using the same spinal cord RNAs (experiment 1) and by qRT-
PCR of spinal cord RNAs from an independent mouse infection
experiment (experiment 2). In each experiment, the samples
were obtained from spinal cords of both infected and mock
infected mice (3-5 mice), sacrificed at 33dpi. All nine transcripts
were significantly induced using both techniques of
measurement and in RNA samples from both experiments. T-
tests were performed to assess significant induction in the
qRT-PCR analysis. Data plotted are means with SEM.
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Figure S3.  Oligodendrocyte-specific gene expression. As
described in the legend to Figure 3, qRT-PCR primers were
used to detect the level of expression of oligodendrocyte
specific gene transcripts in spinal cords recovered from mock
or MHV-A59 infected mice (33dpi). None of the genes had
significantly altered expression in infected mice compared to
mock. Data shown are means with SEM.
(TIFF)
Table S1.  RNA-seq library statistics.
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Table S2.  Genes whose expression was increased in the
MHV-infected spinal cord.
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Table S3.  Gene ontology analysis of 894 upregulated
genes.
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Table S4.  Cytokines and cytokine receptors.
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Table S5.  Antigen Presentation.
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Table S6.  Lipid and cholesterol transport and metabolism.
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function.
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